Gil Blum

Stock Analyst at Needham

(3.64)
# 827
Out of 5,044 analysts
425
Total ratings
40.59%
Success rate
9.8%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Gil Blum

Nurix Therapeutics
Oct 22, 2025
Maintains: Buy
Price Target: $27$26
Current: $11.85
Upside: +119.41%
Celcuity
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $74.51
Upside: -6.05%
Autolus Therapeutics
Oct 20, 2025
Reiterates: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Artiva Biotherapeutics
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $4.71
Upside: +282.17%
CRISPR Therapeutics AG
Oct 10, 2025
Reiterates: Buy
Price Target: $81
Current: $63.31
Upside: +27.94%
Absci
Aug 13, 2025
Maintains: Buy
Price Target: $9$8
Current: $4.43
Upside: +80.59%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $86.62
Upside: +21.22%
Fate Therapeutics
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.44
Upside: -
I-Mab
Oct 24, 2025
Suspends: Buy
Price Target: $6
Current: $4.63
Upside: +29.59%
Taysha Gene Therapies
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $4.96
Upside: +101.61%
Upgrades: Buy
Price Target: $14
Current: $8.81
Upside: +58.91%
Reiterates: Buy
Price Target: $8
Current: $5.94
Upside: +34.68%
Reiterates: Buy
Price Target: $15
Current: $5.83
Upside: +157.29%
Reiterates: Buy
Price Target: $10
Current: $2.14
Upside: +367.29%
Reiterates: Underperform
Price Target: n/a
Current: $23.77
Upside: -
Maintains: Hold
Price Target: n/a
Current: $3.85
Upside: -
Maintains: Buy
Price Target: $7$5
Current: $2.07
Upside: +141.55%
Maintains: Buy
Price Target: $41$40
Current: $8.35
Upside: +379.33%
Reiterates: Buy
Price Target: $71
Current: $33.43
Upside: +112.38%
Reiterates: Buy
Price Target: $9
Current: $2.05
Upside: +339.02%
Reiterates: Hold
Price Target: n/a
Current: $1.93
Upside: -
Reiterates: Buy
Price Target: $5
Current: $1.27
Upside: +295.26%
Reiterates: Buy
Price Target: $48
Current: $11.22
Upside: +327.81%